TrialHepatology (Baltimore, Md.)2016

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2).

Eric Lawitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.